NxStage Medical, Inc. is a medical technology company that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. 
Its primary product includes the NxStage System One (the System One). NxStage operates in two segments: System One and In-Center. The Company markets the System One to hospitals for treatment of acute kidney failure and fluid overload. In addition to the System One, NxStage sells a line of extracorporeal disposable products for use primarily for in-center dialysis treatments for patients with end-stage renal disease (ESRD). These products, which consist of Medisystems, include hemodialysis blood tubing sets, A.V. fistula needles and apheresis needles. The Company's blood tubing set products include the ReadySet High Performance Blood Tubing set (ReadySet), and the Streamline Airless Blood Tubing set (Streamline).

Type
Subsidiary
HQ
Lawrence, US
Founded
1998
NxStage Medical was founded in 1998 and is headquartered in Lawrence, US
Report incorrect company information

NxStage Medical Office Locations

NxStage Medical has an office in London, Birmingham, Los Angeles, Nashville and in 43 other locations
Lawrence, US (HQ)
350 Merrimack St
Brunswick, US
1418 Town Center Blvd
Casselberry, US
d102 174 FL-436
Cincinnati, US
12065 Montgomery Rd
Coconut Creek, US
7525 FL-7
Dublin, US
5665 Woerner Temple Rd
Show all (47)
Report incorrect company information

NxStage Medical Financials and Metrics

Summary Metrics

Founding Date

1998
NxStage Medical is a subsidiary of Fresenius Medical Care

NxStage Medical Financials

NxStage Medical's revenue was reported to be $366.38 m in FY, 2016 which is a 9% increase from the previous period.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

263.4 m301.5 m336.1 m366.4 m

Revenue growth, %

14%11%9%

Cost of goods sold

160.9 m185.6 m204.7 m214.4 m

Gross profit

102.5 m115.9 m131.5 m152 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

66.9 m72.2 m74.1 m75.3 m79.5 m80.3 m86.5 m89.2 m92.2 m92 m96.8 m96.2 m

Cost of goods sold

41.3 m43.3 m46.6 m46.7 m49.4 m49.5 m51.8 m52.7 m53.8 m52.8 m55.6 m55.1 m

Gross profit

25.5 m28.9 m27.5 m28.6 m30.1 m30.9 m34.7 m36.5 m38.4 m39.2 m41.2 m41.2 m

Gross profit Margin, %

38%40%37%38%38%38%40%41%42%43%43%43%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

84.1 m52.9 m59.1 m59.6 m

Accounts Receivable

20.2 m24.1 m25.2 m32.3 m

Inventories

4 m6.8 m6.3 m46.8 m

Current Assets

146.1 m129.2 m128.9 m144.9 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

83.2 m76.8 m62.1 m54.6 m51 m48.4 m51.3 m57.7 m58.5 m60.8 m55.5 m62.8 m

Accounts Receivable

22.5 m25.3 m31.1 m27.1 m24 m26.4 m30.6 m29.1 m30.1 m30.6 m39.3 m31.9 m

Inventories

37.1 m40.8 m43.4 m47.9 m45.3 m43.4 m42.6 m39 m41.3 m46.9 m48.5 m51.2 m

Current Assets

147.8 m147 m141.1 m134.4 m126.7 m124.4 m131.5 m131.7 m135.8 m144.2 m151.2 m155.5 m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(18.6 m)(24.3 m)(16.3 m)(7.3 m)

Depreciation and Amortization

24.8 m27.7 m30.7 m32.6 m

Inventories

(20 m)(35 m)(12 m)(31.1 m)

Accounts Payable

(2.2 m)(212 k)(2.8 m)3.5 m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(5 m)(5.3 m)(7.2 m)(6.8 m)(5.9 m)(5.6 m)(2 m)(1.8 m)(2.2 m)(890 k)(1.5 m)

Inventories

43.4 m47.9 m45.3 m43.4 m42.6 m39 m41.3 m46.9 m48.5 m

Accounts Payable

22.5 m22.6 m17 m12.8 m12.8 m14.1 m13.6 m14.8 m18.5 m
Show all financial metrics
Report incorrect company information